
Tim Luongo
233 posts

Tim Luongo
@timluongo
Early‑stage Biotech Advisor | Founder & Principal @ BridgeLine Translational Partners | Discovery, Nonclinical & Portfolio Strategy • Investor Readiness













Congrats to @PaulTitchenell for receiving the 2021 New Investigator Award from the APS Endo/Metabolism Section. He will be presenting an award lecture at the 2021 EB Conf. highlighting his work on insulin action/metabolism @APSPhysiology @PennMedNews @PennMedEVDCSO @PennMedNews



A peptide molecule that competes with a disease-linked enzyme could potentially lower the risk of #HeartFailure and hypertrophy resulting from pressure overload, which can arise from conditions such as hypertensive heart disease. @SciSignal #cardiology fcld.ly/kk9m0oj

Tuesday: pre-print led by @guischu09 at @biorxivpreprint! Thursday: new spectacular paper, led by @IgorCamargoF, online! Friday: A major effort on astrocyte biomarkers led by @BellaverBruna just accepted! What a week for the @zimmerneurolab! 🔥🧠🔥







